Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytokine storm and sepsis disease pathogenesis
Benjamin G. Chousterman, Filip K. Świrski, Georg F. Weber
Seminars in Immunopathology (2017) Vol. 39, Iss. 5, pp. 517-528
Closed Access | Times Cited: 1139

Showing 1-25 of 1139 citing articles:

The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Qing Ye, Bili Wang, Jianhua Mao
Journal of Infection (2020) Vol. 80, Iss. 6, pp. 607-613
Open Access | Times Cited: 2698
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang, Zhao Wu, Jiawen Li, et al.
International Journal of Antimicrobial Agents (2020) Vol. 55, Iss. 5, pp. 105954-105954
Open Access | Times Cited: 1751
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Betsy Barnes, José M. Adrover, Amelia Baxter-Stoltzfus, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 6
Open Access | Times Cited: 1447
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, et al.
Cell (2020) Vol. 184, Iss. 1, pp. 149-168.e17
Open Access | Times Cited: 1260
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
Wen Zhang, Yan Zhao, Fengchun Zhang, et al.
Clinical Immunology (2020) Vol. 214, pp. 108393-108393
Open Access | Times Cited: 1259
Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
Ahmet Kürşat Azkur, Mübeccel Akdiş, Dilek Azkur, et al.
Allergy (2020) Vol. 75, Iss. 7, pp. 1564-1581
Open Access | Times Cited: 1111
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo Bonaventura, Alessandra Vecchié, Lorenzo Dagna, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 319-329
Open Access | Times Cited: 790
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 727
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 502
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhe Zhu, Ting Cai, Lingyan Fan, et al.
International Journal of Infectious Diseases (2020) Vol. 95, pp. 332-339
Open Access | Times Cited: 420
Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
Paul C. Evans, G. Ed Rainger, Justin C. Mason, et al.
Cardiovascular Research (2020) Vol. 116, Iss. 14, pp. 2177-2184
Open Access | Times Cited: 415
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 389
SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression
Rúbens Cecchini, Alessandra Lourenço Cecchini
Medical Hypotheses (2020) Vol. 143, pp. 110102-110102
Open Access | Times Cited: 354
Immune-mediated approaches against COVID-19
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich‐Koubi, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 630-645
Open Access | Times Cited: 335
Thrombosis in COVID‐19
Thomas C. Hanff, Amir M. Mohareb, Jay Giri, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 12, pp. 1578-1589
Open Access | Times Cited: 298
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 266
Plants as Sources of Anti-Inflammatory Agents
Clara dos Reis Nunes, Mariana Barreto de Souza Arantes, Sílvia Menezes de Faria Pereira, et al.
Molecules (2020) Vol. 25, Iss. 16, pp. 3726-3726
Open Access | Times Cited: 265
Sepsis—Pathophysiology and Therapeutic Concepts
Dominik Jarczak, Stefan Kluge, Axel Nierhaus
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 255
Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Christian Zanza, Tatsiana Romenskaya, A Manetti, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 144-144
Open Access | Times Cited: 249
Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes
Franck Mauvais‐Jarvis, Sabra L. Klein, Ellis R. Levin
Endocrinology (2020) Vol. 161, Iss. 9
Open Access | Times Cited: 238
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Ana Copaescu, Olivia Smibert, Andrew Gibson, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 3, pp. 518-534.e1
Open Access | Times Cited: 234
The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review
Hengfeng Liao, Jun Ye, Lili Gao, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 133, pp. 110917-110917
Open Access | Times Cited: 219
Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review
Charis M. Galanakis, Turki M.S. Aldawoud, Myrto Rizou, et al.
Foods (2020) Vol. 9, Iss. 11, pp. 1701-1701
Open Access | Times Cited: 218
Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications
Masae Iwasaki, Junichi Saito, Hailin Zhao, et al.
Inflammation (2020) Vol. 44, Iss. 1, pp. 13-34
Open Access | Times Cited: 206
Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
Ruocong Yang, Hao Liu, Chen Bai, et al.
Pharmacological Research (2020) Vol. 157, pp. 104820-104820
Open Access | Times Cited: 203
Page 1 - Next Page

Scroll to top